medecolМедицина и экологияMedicine and ecology2305-60452305-6053Карагандинский медицинский университетmedecol-331Research ArticleОРГАНИЗАЦИЯ И ЭКОНОМИКА ЗДРАВООХРАНЕНИЯORGANIZATION AND ECONOMICS OF HEALTHПути повышения информированности населения о системе фармаконадзораWays to increase public awareness of the pharmacovigilance systemЕсенбековаА. Б.EsenbekovaA. B.

Алия Беркуткызы Есенбекова – магистрант специальности «фармация»

Караганда

Karaganda

Esenbekova_A@qmu.kzБолатбекА. Ж.BolatbekA. Zh.

Караганда

Karaganda

ЛосеваИ. В.LossevaI. V.

Караганда

Karaganda

Медицинский университет КарагандыКазахстанKaraganda medical universityKazakhstan202228052023033338Copyright © Есенбекова А.Б., Болатбек А.Ж., Лосева И.В., 20232023Есенбекова А.Б., Болатбек А.Ж., Лосева И.В.Esenbekova A.B., Bolatbek A.Z., Losseva I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medecol.qmu.kz/jour/article/view/331

Целью данной работы стало определение путей повышения информированности населения о системе мониторинга нежелательных реакций лекарственных препаратов. С этой целью был проведен систематический анализ литературы из доступных источников в базах данных MEDLINE (PubMed), Trip Database, Cochrane Library. Главном способом сбора информации фармаконадзора о нежелательных лекарственных реакциях является система спонтанных сообщений, которые могут быть отправлены работниками здравоохранения и пациентами. На сегодняшний день и ВОЗ, и Европейский Союз признают важность прямых сообщений пациентов, позволяющим своевременно обнаружить новые и редкие нежелательные реакции. Однако, несмотря на это существуют проблемы недостатка карт-сообщений пациентов и их низкой информированности о системе фармаконадзора. В данной публикации анализируются причины недостатка таких сообщений и мероприятия, направленные на продвижение и увеличение количества сообщений о нежелательных реакциях на опыте разных стран. С учетом разности культур и ценностей, а также изменчивости условий на сегодняшний день, используемые методы не всегда могут подходить для полного решения проблемы. Поэтому разработка новых и адаптация уже созданных методов является актуальным вопросом на сегодняшний день.

The purpose of this work was to identify ways to increase public awareness of the monitoring system for adverse drug reactions. For this purpose, a systematic analysis of the literature from available sources in the MEDLINE (PubMed), Trip Database, Cochrane Library databases was carried out. The main way to collect information about adverse drug reactions for pharmacovigilance is through a system of spontaneous reports that can be sent by healthcare professionals and patients. Today, both the WHO and the European Union recognize the importance of direct patient reporting in order to detect new and rare adverse reactions in a timely manner. However, despite this, there are problems of under-reporting of adverse drug reactions and patient’s low awareness of the pharmacovigilance system. This publication analyzes the reasons for under-reporting and activities aimed at promoting and increasing the number of reports of adverse reactions based on the experience of different countries. Given the difference in cultures and values of countries, as well as the variability of conditions today, the methods used may not always be suitable for a complete solution of the problem. Therefore, the development of new and adaptation of already created methods is a topical issue today.

фармаконадзорспонтанные сообщениянежелательные лекарственные реакцииpharmacovigilancespontaneous reportsadverse drug reactionsReferencesАсецкая И. Л. Система фармаконадзора в Евразийском экономическом союзе / И. Л. Асецкая, С. К. Зырянов, А. С. Колбин, Д. Ю. Белоусов // Качественная клиническая практика. – 2018. – №4. – С. 53-72.Aseckaya I. L. Sistema farmakonadzora v Evrazijskom e’konomicheskom soyuze / I. L. Aseckaya, S. K. Zyryanov, A. S. Kolbin, D. Yu. Belousov // Kachestvennaya klinicheskaya praktika. – 2018. – №4. – С. 53-72.Приказ Министра здравоохранения Республики Казахстан от 23 декабря 2020 года № ҚР ДСМ-320/2020 «Об утверждении правил проведения фармаконадзора и мониторинга безопасности, качества и эффективности медицинских изделий».Prikaz Ministra zdravooxraneniya Respubliki Kazaxstan ot 23 dekabrya 2020 goda № ҚR DSM-320/2020 «Ob utverzhdenii pravil provedeniya farmakonadzora i monitoringa bezopasnosti, kachestva i e’ffektivnosti medicinskix izdelij».Фармаконадзор и мониторинг побочных действий [Электронный ресурс] / Национальный центр экспертизы лекарственных средств и медицинских изделий. – Электрон. текстовые дан. – Режим доступа: https://www.ndda.kz/pages/farmakonadzor-i-monitoring-pobochnykhdeistvii_1453112234. – Загл. с экрана.Farmakonadzor i monitoring pobochnyx dejstvij [E’lektronnyj resurs] / Nacional’nyj centr e’kspertizy lekarstvennyx sredstv i medicinskix izdelij. – E’lektron. tekstovye dan. – Rezhim dostupa: https://www.ndda.kz/pages/farmakonadzor-imonitoring-pobochnykh-deistvii_1453112234. – Zagl. s e’krana.Al Dweik R. Factors affecting patient reporting of adverse drug reactions: a systematic review / R. Al Dweik, D. Stacey, D. Kohen, S. Yaya // British Journal of Clinical Pharmacology. – 2017. – V. 83 (4). – P. 875-883.Al Dweik R. Factors affecting patient reporting of adverse drug reactions: a systematic review / R. Al Dweik, D. Stacey, D. Kohen, S. Yaya // British Journal of Clinical Pharmacology. – 2017. – V. 83 (4). – P. 875-883.Almandil Noor B. Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance / Noor B. Almandil // Saudi Medical Journal. – 2016. – V. 37 (12). – P. 1359-1364.Almandil Noor B. Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance / Noor B. Almandil // Saudi Medical Journal. – 2016. – V. 37 (12). – P. 1359-1364.Alomar M. Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future / M. Alomar, A. M. Tawfiq, N. Hassan, S. Palaian // Therapeutic Advances in Drug Safety. – 2020. – V. 11. – ISSN 2042-0986.Alomar M. Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future / M. Alomar, A. M. Tawfiq, N. Hassan, S. Palaian // Therapeutic Advances in Drug Safety. – 2020. – V. 11. – ISSN 2042-0986.Bahk C. Y. Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US / C. Y. Bahk, M. Goshgarian, K. Donahue, C. C. Freifeld, C. M. Menone, C. E. Pierce, H. Rodriguez, J. S. Brownstein, R. Furberg, N. Dasgupta // Pharmaceutical Medicine. – 2015. – V. 29 (6). – P. 331-340.Bahk C. Y. Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US / C. Y. Bahk, M. Goshgarian, K. Donahue, C. C. Freifeld, C. M. Menone, C. E. Pierce, H. Rodriguez, J. S. Brownstein, R. Furberg, N. Dasgupta // Pharmaceutical Medicine. – 2015. – V. 29 (6). – P. 331-340.de Vries S. T. Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK / S. T. de Vries, P. Denig, A. Andrić, Di Giusti M. Dimov, A. Ptaszynska-Neophytou, L. Härmark, P. G. M. Mol ; on behalf of the IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package 4 // Drug Safety. – 2021. – V. 44 (10). – P. 1073-1083.de Vries S. T. Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK / S. T. de Vries, P. Denig, A. Andrić, Di Giusti M. Dimov, A. Ptaszynska-Neophytou, L. Härmark, P. G. M. Mol ; on behalf of the IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package 4 // Drug Safety. – 2021. – V. 44 (10). – P. 1073-1083.Hadi M. A. Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting / M. A. Hadi, C. F. Neoh, R. M. Zin, M. E. Elrggal, E. Cheema // Integrated Pharmacy Research and Practice. – 2017. – V. 6. – P. 91-98.Hadi M. A. Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting / M. A. Hadi, C. F. Neoh, R. M. Zin, M. E. Elrggal, E. Cheema // Integrated Pharmacy Research and Practice. – 2017. – V. 6. – P. 91-98.Inácio P. The value of patient reporting to the pharmacovigilance system: a systematic review / P. Inácio, A. Cavaco, M. Airaksinen // British Journal of Clinical Pharmacology. – 2017. – V. 83 (2). – P. 227-246.Inácio P. The value of patient reporting to the pharmacovigilance system: a systematic review / P. Inácio, A. Cavaco, M. Airaksinen // British Journal of Clinical Pharmacology. – 2017. – V. 83 (2). – P. 227-246.Islam M. A. Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia / M. A. Islam, A. F. Al-Karasneh, A. A. Naqvi, D. M. AlShayban, F. Al-Hayek, S. Al-Badrani, R. Al-Salem, S. A. Ghori // Pharmacy. – 2020. – V. 8 (4) : 222.Islam M. A. Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia / M. A. Islam, A. F. Al-Karasneh, A. A. Naqvi, D. M. AlShayban, F. Al-Hayek, S. Al-Badrani, R. AlSalem, S. A. Ghori // Pharmacy. – 2020. – V. 8 (4) : 222.Ito S. Estimation of the Under-Reporting of Suspected Serious Adverse Drug Reactions in Japan Using An Interrupted Time Series Analysis / S. Ito, M. Narukawa // Therapeutic Innovation & Regulatory Science. – 2022. – V. 56 (2). – P. 358-365.Ito S. Estimation of the Under-Reporting of Suspected Serious Adverse Drug Reactions in Japan Using An Interrupted Time Series Analysis / S. Ito, M. Narukawa // Therapeutic Innovation & Regulatory Science. – 2022. – V. 56 (2). – P. 358-365.Kim S. A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers / S. Kim, Y. M. Yu, M. You, K. H. Jeong, E. Lee // BMC Public Health. – 2020. – V. 20 : 1527.Kim S. A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers / S. Kim, Y. M. Yu, M. You, K. H. Jeong, E. Lee // BMC Public Health. – 2020. – V. 20 : 1527.Lopez-Gonzalez E. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial / E. Lopez-Gonzalez, M. T. Herdeiro, M. Piñeiro-Lamas, A. Figueiras ; On behalf of the GREPHEPI group // Drug Safety. – 2015. – V. 38 (2). – P.189-196.Lopez-Gonzalez E. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial / E. Lopez-Gonzalez, M. T. Herdeiro, M. Piñeiro-Lamas, A. Figueiras ; On behalf of the GREPHEPI group // Drug Safety. – 2015. – V. 38 (2). – P.189-196.Ribeiro-Vaz I. How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis/ I. RibeiroVaz, A. M. Silva, C. Costa Santos, R. Cruz-Correia // BMC Medical Informatics and Decision Making. – 2016. – V. 16 : 27.Ribeiro-Vaz I. How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis/ I. RibeiroVaz, A. M. Silva, C. Costa Santos, R. Cruz-Correia // BMC Medical Informatics and Decision Making. – 2016. – V. 16 : 27.Safety monitoring of medical products: reporting system for the general public [Электронный ресурс] / World Health Organization. – Электрон. текстовые дан. – Geneva: World Health Organization. – 2012. – 26 p. – ISBN 9789241503198.Safety monitoring of medical products: reporting system for the general public [Электронный ресурс] / World Health Organization. – Электрон. текстовые дан. – Geneva: World Health Organization. – 2012. – 26 p. – ISBN 9789241503198.Sales I. Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia / I. Sales, H. Aljadhey, Y. Albogami, M. A. Mahmoud // Saudi Pharmaceutical Journal. – 2017. – V. 25 (6). – P. 868-872.Sales I. Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia / I. Sales, H. Aljadhey, Y. Albogami, M. A. Mahmoud // Saudi Pharmaceutical Journal. – 2017. – V. 25 (6). – P. 868-872.Salgueiro E. What can we learn from the public’s understanding of drug information and safety? A population survey / E. Salgueiro, C. Gurruchaga, F. J. Jimeno, C. Martínez-Múgica, L. H. Martín Arias, G. Manso // International Journal of Pharmacy Practice. – 2019. – V. 27 (1). – P. 96-104.Salgueiro E. What can we learn from the public’s understanding of drug information and safety? A population survey / E. Salgueiro, C. Gurruchaga, F. J. Jimeno, C. Martínez-Múgica, L. H. Martín Arias, G. Manso // International Journal of Pharmacy Practice. – 2019. – V. 27 (1). – P. 96-104.Sandberg A. Under-Reporting of Adverse Drug Reactions in Finland and Healthcare Professionals’ Perspectives on How to Improve Reporting / A. Sandberg, V. Salminen, S. Heinonen, M. Sivén // Healthcare. – 2022. – V. 10 (6) : 1015Sandberg A. Under-Reporting of Adverse Drug Reactions in Finland and Healthcare Professionals’ Perspectives on How to Improve Reporting / A. Sandberg, V. Salminen, S. Heinonen, M. Sivén // Healthcare. – 2022. – V. 10 (6) : 1015Suyagh M. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process / M. Suyagh, D. Farah, R. Abu Farha // Saudi Pharmaceutical Journal. – 2015. – V. 23 (2). – P. 147-153.Suyagh M. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process / M. Suyagh, D. Farah, R. Abu Farha // Saudi Pharmaceutical Journal. – 2015. – V. 23 (2). – P. 147-153.Vaismoradi M. Adverse Drug Reactions in Norway: A Systematic Review / M. Vaismoradi, P. A. Logan, S. Jordan, H. Sletvold // Pharmacy. – 2019. – V. 7 (3) : 102Vaismoradi M. Adverse Drug Reactions in Norway: A Systematic Review / M. Vaismoradi, P. A. Logan, S. Jordan, H. Sletvold // Pharmacy. – 2019. – V. 7 (3) : 102van Hunsel F. Experiences with adverse drug reaction reporting by patients: an 11-country survey / F. van Hunsel, L. Härmark, S. Pal, S. Olsson, K. van Grootheest // Drug Safety. – 2012. – V. 35 (1). – P. 45-60.van Hunsel F. Experiences with adverse drug reaction reporting by patients: an 11-country survey / F. van Hunsel, L. Härmark, S. Pal, S. Olsson, K. van Grootheest // Drug Safety. – 2012. – V. 35 (1). – P. 45-60.van Hunsel F. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands / F. van Hunsel, C. van der Welle, A. Passier, E. van Puijenbroek, K. van Grootheest // European Journal of Clinical Pharmacology. – 2010. – V. 66 (11). – P. 1143-1150.van Hunsel F. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands / F. van Hunsel, C. van der Welle, A. Passier, E. van Puijenbroek, K. van Grootheest // European Journal of Clinical Pharmacology. – 2010. – V. 66 (11). – P. 1143-1150.

The authors declare that there are no conflicts of interest present.